Global Neurology Academy

OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Global Neurology Academy
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
- Mike Sharma, MD, MSc, FRCPC
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Global Neurology Academy
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
- Ashkan Shoamanesh, MD
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Global Neurology Academy
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
- Alexandria May, PharmD, BCPS
- Apurva Bhatt, MD
CME/CE In-Person Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
Optimizing Vitamin D Supplementation in MS Care
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiers
Optimizing Vitamin D Supplementation in MS Care
Evaluating Structured Interventions for Cognitive Support in MS
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstracts
Evaluating Structured Interventions for Cognitive Support in MS
- Hallie Blevins, PhD
How Muscarinic Therapies Are Redefining Schizophrenia Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiers
How Muscarinic Therapies Are Redefining Schizophrenia Care
- Michael Halassa, MD, PhD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD

Medical News

Medical News
EBV-Specific CD8+ T Cells in CSF: New Insights Into Early MS Immune Biology
02/09/2026
Read more
Medical News
Localized IL-15 Immunotherapy with a Delayed-Release Implant for Glioblastoma
02/05/2026
Read more
Medical News
Computational Network Study Highlights CD44 as a Potential MS Target
02/05/2026
Read more
Medical News
Validating the Arabic MOS Pain Effects Scale for Adults With MS
02/05/2026
Read more

See more news

CME/CE

CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
New Pathways in the Treatment of DMD
New Pathways in the Treatment of DMD
CME/CE
New Pathways in the Treatment of DMD
1.00 credit
- Erika Finanger, MD, MS
- Aravindhan Veerapandiyan, MD
1.00 credit
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CE
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
1.00 credit
- Stephen Chrzanowski, MD, PhD
- Aravindhan Veerapandiyan, MD
1.00 credit

Clinical Practice

CME/CE In-Person & Virtual Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiers
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
- Jerome Lisk, MD, MBA, M.S., FAAN
- Michael Salvatore, PhD
- Vicki Nejtek-Salvatore, PhD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP

Programs

The Role of Neurofilament Light Chain in MS Management
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiers
The Role of Neurofilament Light Chain in MS Management
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
- Jeffrey A. Lieberman, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
Global Neurology Academy
Digital Danger: Understanding AI Psychosis in Schizophrenia
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS